DE
Therapeutic Areas
C4X Discovery Pipeline
| Drug | Indication | Phase |
|---|---|---|
| α4β7 integrin inhibitor programme | Immuno-inflammatory diseases | Pre-clinical |
| Partnered programme with Sanofi | Immuno-inflammatory disease (undisclosed) | Discovery/Pre-clinical |
| Partnered programme with AstraZeneca | Inflammatory disease (undisclosed) | Discovery/Pre-clinical |